Miralax

Constipation, Exophthalmos, Bowel preparation therapy + 8 more
Treatment
3 FDA approvals
20 Active Studies for Miralax

What is Miralax

Polyethylene glycolThe Generic name of this drug
Treatment SummaryPolyethylene glycol (PEG) is a synthetic polymer made from ethylene glycol molecules joined by an ether linkage. Depending on the molecular weight, PEGs can be liquids or waxy solids. The most common types are PEG 3350 and PEG 400. PEGs have different applications in medical and industrial fields. PEG 3350 is an over-the-counter osmotic laxative used to treat constipation, and PEG 3350 is also used to cleanse the colon before a colonoscopy. PEGs are useful in gastroenterology because they have strong water-binding capacity
GoLYTELYis the brand name
image of different drug pills on a surface
Miralax Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
GoLYTELY
Polyethylene glycol
1984
207

Approved as Treatment by the FDA

Polyethylene glycol, also known as GoLYTELY, is approved by the FDA for 3 uses such as Constipation and Constipation .
Constipation
Constipation
Constipation

Effectiveness

How Miralax Affects PatientsPEG 3350 causes diarrhea by increasing the amount of water in the intestines. Effects usually start within 1-2 hours after taking it. When used to prepare for a colonoscopy, it is often combined with electrolytes to prevent dehydration. Over-the-counter versions of PEG 3350 do not contain any salts that can be absorbed. Studies have shown that it does not affect the ability of the intestines to absorb fluids or create and maintain electrochemical gradients.
How Miralax works in the bodyOsmotic laxatives contain substances that draw water into the large intestine, making the stool softer and easier to pass. One such substance is polyethylene glycol, which binds to water molecules and causes them to accumulate in the colon. This accumulation leads to looser stools.

When to interrupt dosage

The recommended dosage of Miralax is contingent upon the diagnosed disorder, such as Dry Eye Syndrome, Bowel preparation therapy and Chronic Constipation. The quantity of dosage may deviate, depending on the method of delivery outlined in the table hereunder.
Condition
Dosage
Administration
Colonoscopy
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Colon Cleansing for Colonoscopy
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Constipation
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Dry Eye Syndrome
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Constipation
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Exophthalmos
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Dry Eye Syndrome
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Bowel preparation therapy
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Chronic Constipation
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Obesity
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal
Eye
, 1.7 mg/mg, 236.0 mg/mL, 17000.0 mg, 1700.0 mg/hour, 420.0 mg/mL, 17.0 mg/mg, 2.4 mg/mg, 4.2 mg/mg, 2.36 mg/mg, 227.1 mg/mL, 210.0 mg/mL, 1.0 mg/mg, 0.55 mg/mg, 100.0 %, 1.0 %, 15.0 %, 236000.0 mg, 59550.0 mg, 238180.0 mg, 14750.0 mg, 59000.0 mg, 240.0 mg/mL, 10.0 mg/mL, 150.0 mg/mL, 210000.0 mg, 0.15 mg/mg, 100.0 mg/mL, 40000.0 mg, 60.0 mg/mL, 100000.0 mg, 0.2 %, 140000.0 mg, 17000.0 mg/dose, 160.0 mg/mL, 0.152 mg/mg, 0.85769 mg/mg, 59.55 mg/mL, 2.388 mg/mg, 2.382 mg/mg
Oral, , Powder, for solution, Powder, for solution - Oral, Powder, Powder - Oral, Powder, for solution - Topical, Topical, Powder, for solution - Nasogastric; Oral, Nasogastric; Oral, Cream, Cream - Topical, Ophthalmic, Liquid, Liquid - Ophthalmic, Gel - Nasal, Gel, Nasal, Kit; Powder, for solution; Tablet, delayed release, Kit; Powder, for solution; Tablet, delayed release - Oral, Spray, metered, Spray, metered - Nasal, Spray - Nasal, Spray, Gel - Topical, Solution, Solution - Oral, Liquid - Oral, Powder - Topical, Nasogastric, Powder, for solution - Nasogastric, Kit, Kit - Oral, Aerosol, metered - Nasal, Aerosol, metered, Powder, for suspension - Oral, Powder, for suspension, Solution - Ophthalmic, Oral; Topical, Kit - Oral; Topical, Solution / drops, Solution / drops - Ophthalmic, Oral; Rectal

Warnings

Miralax Contraindications
Condition
Risk Level
Notes
Toxic colitis
Do Not Combine
Intestinal Perforation
Do Not Combine
Megacolon, Toxic
Do Not Combine
Gastric Retention
Do Not Combine
Gastrointestinal obstruction
Do Not Combine
Ileus
Do Not Combine
There are 20 known major drug interactions with Miralax.
Common Miralax Drug Interactions
Drug Name
Risk Level
Description
Bisacodyl
Major
The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Bisacodyl.
Bisoxatin
Major
The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Bisoxatin.
Dantron
Major
The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Dantron.
Deacetylbisacodyl
Major
The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Deacetylbisacodyl.
Oxyphenisatin
Major
The risk or severity of mucosal ulceration and ischemic colitis can be increased when Polyethylene glycol is combined with Oxyphenisatin.
Miralax Toxicity & Overdose RiskThe lowest toxic dose of PEG 3350 in rats has been found to be 22000 mg/kg. Too much PEG 3350 may cause diarrhea, and those who overdose should be given supportive treatments to help with their symptoms.
image of a doctor in a lab doing drug, clinical research

Miralax Novel Uses: Which Conditions Have a Clinical Trial Featuring Miralax?

67 active clinical trials are being conducted to determine the utility of Miralax in providing Bowel preparation therapy, Body weight >20kg and Exophthalmos relief.
Condition
Clinical Trials
Trial Phases
Exophthalmos
2 Actively Recruiting
Phase 2, Phase 3
Constipation
18 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1
Constipation
0 Actively Recruiting
Colon Cleansing for Colonoscopy
0 Actively Recruiting
Eye
0 Actively Recruiting
Chronic Constipation
1 Actively Recruiting
Not Applicable
Dry Eye Syndrome
8 Actively Recruiting
Phase 2, Phase 1, Phase 4, Not Applicable
Bowel preparation therapy
1 Actively Recruiting
Phase 1, Phase 2
Obesity
0 Actively Recruiting
Dry Eye Syndrome
9 Actively Recruiting
Phase 2, Phase 4, Not Applicable
Colonoscopy
3 Actively Recruiting
Not Applicable

Miralax Reviews: What are patients saying about Miralax?

5Patient Review
8/14/2022
Miralax for Incomplete or Infrequent Bowel Movements
I've had chronic constipation since childhood and it's only gotten worse as I've aged. Miralax is a lifesaver that helps me avoid severe symptoms on a daily basis.
5Patient Review
10/1/2022
Miralax for Incomplete or Infrequent Bowel Movements
I've had IBS for over 30 years, and this is the best treatment I've ever found. Thank you, Marilax!
5Patient Review
12/13/2019
Miralax for Emptying of the Bowel
This medication helped me heal my fissure quickly and effectively.
4.7Patient Review
9/4/2019
Miralax for Incomplete or Infrequent Bowel Movements
I've been trying different treatments for my constipation for many years now, and Miralax seems to be doing the best job. I'm using it daily in combination with magnesium citrate, and so far so good.
4Patient Review
8/25/2021
Miralax for Incomplete or Infrequent Bowel Movements
I take this medication every day without any issues. It's very effective and I'm 74 years old.
4Patient Review
2/4/2019
Miralax for Incomplete or Infrequent Bowel Movements
The product works well, but I have difficulty holding and measuring the dosage from the container.
3.7Patient Review
12/30/2021
Miralax for Incomplete or Infrequent Bowel Movements
This medication does help, but I often feel nauseous after taking it.
2.7Patient Review
8/18/2019
Miralax for Incomplete or Infrequent Bowel Movements
I experienced some very severe and unpleasant side effects after taking only one dose of this product. I ended up in the emergency room with cramping, dizziness, nausea, back pain, and more. Thankfully, the CT scan and blood tests came back normal. However, I will definitely be looking for a different constipation remedy in the future.
2.3Patient Review
9/1/2018
Miralax for Incomplete or Infrequent Bowel Movements
I had some bad abdominal pains after taking this medication for a few days, as prescribed by my doctor. I'm going to look for something else because chronic constipation is an issue for me and I'm getting older.
1.7Patient Review
7/31/2018
Miralax for Incomplete or Infrequent Bowel Movements
While this drug did help with my constipation issue, the back pain it caused was unbearable. I stopped taking it and will never go near it again.
1Patient Review
4/18/2020
Miralax for Incomplete or Infrequent Bowel Movements
I experienced severe stomach pain and rectal bleeding after taking this drug. Additionally, I was incredibly dizzy and did not have a single bowel movement. I believe that a class action lawsuit should be filed against the company for their sale of this dangerous, untested drug.
1Patient Review
11/9/2019
Miralax for Emptying of the Bowel
Unfortunately, this medication caused me a great deal of discomfort. I experienced hot flashes, cramps, and constipation. I stopped and started the medication three different times to be sure it was Miralax that was causing the problems, and it unfortunately was.
1Patient Review
2/8/2022
Miralax for Emptying of the Bowel
I cannot recommend this medication. I began vomiting shortly after taking it as prescribed, and ended up having to cancel my colonoscopy because I couldn't keep the medicine down. This was a terrible experience all around.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about miralax

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is MiraLAX a stool softener or laxative?

"MiraLAX is a laxative that works by drawing water into the colon, which softens the stool and may stimulate the colon to contract. These actions help ease bowel movements. Colace is a stool softener."

Answered by AI

How long does it take for MiraLAX to make you poop?

"MiraLAX typically causes bowel movements to begin within an hour of consumption, but this may differ for some people. There is no need to be concerned if you do not have a bowel movement after drinking the first half of the MiraLAX, simply continue to drink liquids and consume the second half as directed."

Answered by AI

How much does MiraLAX make you poop?

"You can start taking MiraLAX when you first notice constipation, and continuing taking it once a day until you're relieved of constipation (up to 7 days maximum, or as directed by your doctor)."

Answered by AI

What does MiraLAX do to you?

"The purpose of this medication is to treat constipation that occurs occasionally. It does this by causing the stool to retain water which then softens the stool and increases the number of bowel movements. This medication is classified as an osmotic-type laxative."

Answered by AI

Clinical Trials for Miralax

Image of Kannar Eye Care in Pittsburg, United States.

Acoltremon for Dry Eye Syndrome

18 - 75
All Sexes
Pittsburg, KS
This 1-month, 3-visit study will be conducted at the Southern College of Optometry (Memphis, TN), Kannarr Eye Care, LLC (Pittsburg, KS) and Complete Eye Care of Medina (Minneapolis, MN). Adults ≥18 years of age who have been diagnosed with DED for at least 6 months and who are currently symptomatic (Eye Dryness VAS Score ≥40) will be recruited. Subjects will have an abnormal Schirmer test of \<10 mm/5 min. Subjects will also be required to score ≤70 on the IDEEL Quality of Life (QoL) Work domain to ensure that their DED symptoms are significantly impacting their ability to do work.9 Subjects will be required to have corrected distance visual acuity of 20/32 (0.2 logMAR) or better.
Phase 4
Recruiting
Kannar Eye Care (+2 Sites)
Have you considered Miralax clinical trials? We made a collection of clinical trials featuring Miralax, we think they might fit your search criteria.Go to Trials
Image of Center for Nutraceutical and Dietary Supplement Research in Memphis, United States.

Inno Cleanse for Abdominal Bloating

18+
All Sexes
Memphis, TN
The purpose of the present study is to investigate the impact of a natural dietary supplement, Inno Cleanse™, to reduce bloating in a population of otherwise healthy men and women, who claim to feel frequently bloated. Inno CleanseTM dietary supplement is manufactured in the United States under current Good Manufacturing Practices (cGMP) and is marketed by InnoSupps as a digestive health aid. It is sold in the United States on the company's website, Amazon, and in many large retail outlets. It remains a very popular product, with close to 1.4 million units sold since 2020, with a reported 66,000 units sold in the past three months. Despite the prevalence of dietary supplements identifying as digestive aids, detoxification, and cleanses, very little research has been done to determine their effectiveness. The product appears to be well-designed, with multiple ingredients included which have scientific evidence of effectiveness. That said, and despite the overall positive reviews, there is no known clinical research to support the product's effectiveness. Therefore, the aim of this study is to evaluate the efficacy of the Inno Cleanse product to reduce bloating and result in other positive outcomes (weight loss). This study will be run as a double-blind placebo-controlled trial, in which subjects will use the product or placebo for two weeks. It is hypothesized that treatment with the dietary supplement Inno Cleanse will result in reduced bloating, as evidenced by self-reported reductions in bloating and hunger, as well as moderate weight loss and a reduction in body circumference measures due to the reduced bloating. In addition, multiple anecdotal reports of improved skin health have been noted in those using the product. Additionally, routine blood and urine sample analysis will be performed as a secondary outcome, as a safety measure.
Recruiting
Paid Trial
Center for Nutraceutical and Dietary Supplement ResearchRichard Bloomer, PhD
Have you considered Miralax clinical trials? We made a collection of clinical trials featuring Miralax, we think they might fit your search criteria.Go to Trials
Image of Banner - University Medical Center South in Tucson, United States.

Dexmedetomidine + Dexamethasone for Postoperative Pain

18 - 75
All Sexes
Tucson, AZ
The goal of this clinical study is to improve upon the standard practice of utilizing nerve blocks to enhance the satisfaction of patients undergoing shoulder, or foot and ankle surgery regarding their quality of pain control, the duration of their nerve blocks, as well as the avoidance of opioid medications and subsequently their undesirable side effects. The researchers hypothesize that dexmedetomidine and dexamethasone (Dex-Dex) will work synergistically as adjuncts in a low, non-weight based formula. This would allow the investigators to improve patient satisfaction by providing them with a superior means of pain control that is longer in duration with a decreased probability of unwanted side effects. The proposed clinical study will be a prospective, randomized control trial.
Phase 1 & 2
Waitlist Available
Banner - University Medical Center SouthRonald Tang, MD
Have you considered Miralax clinical trials? We made a collection of clinical trials featuring Miralax, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security